A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City by Bratu, Simona et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Annals of Clinical Microbiology and 
Antimicrobials
Open Access Research
A population-based study examining the emergence of 
community-associated methicillin-resistant Staphylococcus aureus 
USA300 in New York City
Simona Bratu, David Landman, Jyoti Gupta, Manoj Trehan, Monica Panwar 
and John Quale*
Address: Division of Infectious Diseases, State University of New York – Downstate Medical Center, Brooklyn, New York, USA
Email: Simona Bratu - sbratu@aol.com; David Landman - dlandman@downstate.edu; Jyoti Gupta - jyotiahuja@hotmail.com; 
Manoj Trehan - manojtrehan@yahoo.com; Monica Panwar - mpanwar@msn.com; John Quale* - jquale@downstate.edu
* Corresponding author    
Abstract
Background: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a
serious pathogen in several regions in the United States. It is unclear which populations are at high
risk for the emergence of these strains.
Methods: All unique patient isolates of S. aureus were collected from hospitals in Brooklyn, NY
over a three-month period. Isolates of MRSA that were susceptible to clindamycin underwent
SCCmec typing. Isolates with the SCCmec type IV (characteristic of CA-MRSA strains) underwent
ribotyping. Demographic information involving the neighborhoods of Brooklyn was also gathered
and correlated with the prevalence of CA-MRSA strains.
Results:  Of 1316 isolates collected during the surveillance, 217 were MRSA susceptible to
clindamycin. A total of 125 isolates possessed SCCmec type IV; 72 belonged to the USA300 strain
and five belonged to the USA400 strain. Hospitals in the eastern part of the city had the highest
prevalence of USA300 strain. Individuals in the eastern region, when compared to the western
region, were more likely to be Black, Hispanic, female, and < 18 years of age, and to have
households of ≥ 3 persons. In addition, the median household income was lower, and the
proportion of individuals on public assistance was higher, for the population in the eastern region.
Conclusion: The USA300 strain of CA-MRSA is emerging in New York City. In this population-
based study, urban regions of lower socioeconomic status and with evidence of overcrowding
appear to be at higher risk for the emergence of this pathogen.
Background
Community-associated methicillin-resistant Staphylococ-
cus aureus (CA-MRSA) has emerged as a frequent and seri-
ous pathogen in several regions in the United States. The
CA-MRSA strains have distinctive phenotypic and geno-
typic features when compared to typical hospital-acquired
strains. Most CA-MRSA remain susceptible to other non-
β-lactam antibiotics [1-4]. CA-MRSA strains typically pos-
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sess type IV SCCmec gene and the Panton-Valentine leuko-
cidin (PVL)[1,4,5]. Two distinctive pulsed field gel
electrophoresis types of CA-MRSA have predominated in
the United States [1]. The USA400 type was isolated from
children in the Midwestern United States, and has been
associated with nosocomial infections in neonates and
post-partum women [6-8]. The USA300 type has been
associated with outbreaks in prisons and sports teams,
and has become the predominant type in certain regions
in the United States [2,9,10].
Prior to the emergence of the USA 300/400 strains, most
patients with community-onset MRSA infections had
identifiable risk factors, including recent hospitalization
or nursing home residence, invasive/percutaneous proce-
dure, and/or chronic dialysis therapy [11-13]. However,
initial reports have noted patients with USA300/400
strains have not possessed these risk factors; risk factors
for infection with these strains remain poorly defined.
Most reports of CA-MRSA have examined outbreak situa-
tions; relatively few studies have performed population-
based analyses [14]. In this report, we examine the preva-
lence of CA-MRSA in Brooklyn, NY and examine charac-




From December 2005 through February 2006, all single
patient isolates of S. aureus were gathered from 15 of the
16 hospitals in Brooklyn, NY; the Department of Veterans
Affairs Medical Center, which serves select patients from
throughout the city, was not included in the study. Bacte-
rial isolates were identified by the participating microbiol-
ogy laboratories according to standard techniques.
Susceptibility testing was performed in the central
research laboratory by the agar or broth (for tigecycline
and daptomycin) dilution methods, according to CLSI
standards [15].
Characterization of bacterial isolates
Since susceptibility to clindamycin and possession of
SCCmec IV are typical features of the USA 300/400 strains,
all MRSA isolates gathered in the surveillance study that
were susceptible to clindamycin underwent initial mec
typing according to the methods of Oliveira et al [16]. Iso-
lates that were nontypeable or found to possess a SCCmec
IV underwent further mec characterization according to
the multiplex assay of Zhang et al [17]. Selected isolates
also underwent ribotyping, pulsed field gel electrophore-
sis, and PCR screening for the genes encoding PVL, as pre-
viously described [1,8].
Population-based analysis
Data concerning the city of Brooklyn, and the 72 neigh-
borhoods that comprise the city, were obtained using the
Infoshare Community Data System (Community Studies
of New York, Inc). Demographic, income, and health data
were recorded for each of the neighborhoods. The infor-
mation in this database largely reflects the year 2000 cen-
sus records. The 72 Brooklyn neighborhoods were
assigned, based on location, to one of the 15 hospitals as
the primary medical center delivering care to the neigh-
borhood.
A retrospective chart review was conducted on selected
patients; information collected included demographic
data (including home address), record of recent hospital-
ization, clinical status on presentation, and clinical out-
come (survival).
Statistical analysis included chi square analysis for cate-
gorical data and student's t-test for continuous variables.
This study has been approved by the Institutional Review
Board at SUNY- Downstate Medical Center.
Results
A total of 1316 isolates of S. aureus were collected during
the three-month surveillance study; 581 (44%) were
found to be MRSA (Table 1). Of the MRSA isolates, 217
(37%) were susceptible to clindamycin. SCCmec type IV
was found in 125 (58%) of these isolates (123 with type
IVa and two with type IVb). One isolate possessed SCCmec
type I, 47 possessed type II, and 44 were unable to be
typed. Seventy-five (60%) of the isolates with SCCmec
type IV carried the genes for PVL. Ribotyping was per-
formed on 120 of the 125 (96%) isolates with SCCmec
type IV, and 72 (58%) belonged to the USA300 strain.
PVL genes were identified in 81% of the USA300 isolates.
Only 5 (4%) isolates belonged to the USA400 strain. The
remaining 48 isolates belonged to 12 different ribo-
groups.
Table 1: Overall susceptibility results of 1316 Staphylococcus 
aureus isolates collected in the city-wide surveillance study.
MIC50 MIC90 Range Susceptible
µg/ml
Oxacillin 0.5 >4 ≤.06–>4 56%
Azithromycin >8 >8 ≤0.25–>8 33%
Clindamycin 0.06 >4 ≤.03–>4 66%
Vancomycin 0.5 1 ≤0.25–>1 100%
Ciprofloxacin 4 >4 ≤.06–>4 49%
Daptomycin 0.25 0.5 ≤0.12–1 100%
Tigecycline 0.06 0.25 ≤0.015–0.5 100%
Trimethoprim-sulfamethoxazole ≤0.5 ≤0.5 ≤0.5–>4 96%Annals of Clinical Microbiology and Antimicrobials 2006, 5:29 http://www.ann-clinmicrob.com/content/5/1/29
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Fingerprinting by pulsed field gel electrophoresis corre-
lated well with the ribotyping results. Representative iso-
lates belonging to the same ribogroup as USA300 also had
the same pulsed field type (Fig. 1). To assess if bacteria
with a nontypeable SCCmec  were unrecognized strains
related to either USA300 or USA400 types, seven nontype-
able isolates underwent pulsed field gel electrophoresis.
None of these isolates were closely related to the two CA-
MRSA strains (Fig. 1).
The 72 isolates belonging to the USA300 type were exam-
ined in further detail. Forty-six isolates originated from
wound/soft tissue cultures, seven were from respiratory
specimens, seven were from blood cultures and 12 cul-
tures were from miscellaneous or unidentified sources.
Fifty-one of the 72 (71%) isolates originated from
patients from six hospitals; however, these hospitals sup-
plied 49% of all S. aureus isolates (P < 0.001). The
USA300 strains accounted for 7.9% (range, 6.7–9.2%) of
the S. aureus isolates collected from these six hospitals. In
contrast, the USA300 strains accounted for 3.1% (range
0–5.0%) of the S. aureus isolated from the remaining nine
hospitals.
The six hospitals with the greater prevalence of USA300
strains all serve neighborhoods located in the eastern sec-
tion of the city, while the nine remaining hospitals serve
neighborhoods in the western half of the city (Fig. 2).
During the surveillance period, there were 4.6 cases/
100,000 in the high prevalence region, compared to 1.6
cases/100,000 in the lower region. The populations com-
prising these two regions displayed markedly different
characteristics (Table 2). The population in the high prev-
alence region was more likely to be Black and Hispanic,
female, and less than 18 years of age. Residents in the high
prevalence region were more likely to be economically
disadvantaged, to have ≥ 3 persons per household, and
had a nearly sevenfold increased incidence of newly diag-
nosed HIV infection.
To determine if our selection criteria (clindamycin-sus-
ceptible MRSA) was too restrictive for identifying the
USA300 strains, pulsed field gel electrophoresis was per-
formed on the first four clindamycin-resistant isolates
from six hospitals. To examine for potential bias, 20 iso-
lates originated from hospitals in the western (low preva-
lence) part of the city. None of clindamycin-resistant
MRSA were related to either USA300 or USA400 strains
(Fig. 3).
To determine if patients with cultures positive for the
USA300 strain were representative of the population of
the high prevalence neighborhoods, records of 20 patients
from two medical centers within the higher prevalence
region were reviewed. Of the 20 patients, three were ≤ 18
years of age and 11 were female. Seventeen of the 20
Map of Brooklyn indicating regions with low prevalence  (white area) and high prevalence (gray area) for S. aureus  USA300 strain Figure 2
Map of Brooklyn indicating regions with low prevalence 
(white area) and high prevalence (gray area) for S. aureus 
USA300 strain. Black circles and white X's represent medical 
centers in the low and high prevalence regions, respectively.
Pulsed field gel electrophoresis results for selected MRSA  isolates Figure 1
Pulsed field gel electrophoresis results for selected MRSA 
isolates. Lanes 1–7: clinical isolates belonging to the same 
ribotype as USA300. Lane 8: Clinical isolate belonging to the 
same ribotype as USA400. Lane 9: representative USA400 
strain. Lane 10: lamda ladder. Lane 11: representative 
USA300 isolate. Lanes 12–16: isolates with nontypeable SCC-
mec.Annals of Clinical Microbiology and Antimicrobials 2006, 5:29 http://www.ann-clinmicrob.com/content/5/1/29
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patients resided within the neighborhoods with the
higher prevalence. Two patients were known to be HIV
positive. Prior hospitalization (within the previous year)
was documented in five patients and one patient was on
hemodialysis. Six patients had Medicaid or Medicare as
their health insurance, and only two patients possessed
private health insurance. Race and ethnicity were recorded
in only ten of the patients; nine were Black and one was
white/Hispanic.
Discussion
Several studies, often performed without the benefit of
genetic fingerprinting of the bacterial isolates, found sev-
eral identifiable risk factors (e.g., hospitalization within
one year, nursing home residence, hemodialysis, or place-
ment of a long-term intravascular device) that were asso-
ciated with community-onset MRSA infection or
colonization [11-13]. However, this scenario has changed
dramatically with the emergence of two MRSA strains,
USA300 and USA400. While several well-described out-
breaks involving USA300 (e.g., in prisons and sports
teams) and USA400 (e.g., in postpartum women and
maternity units) have been reported [7-10], risk factors for
acquisition of these strains in the general population are
largely unknown. In Atlanta, patients with skin and soft
tissue infections with the USA300/400 strains were more
Pulsed field gel electrophoresis of clindamycin-resistant clinical isolates Figure 3
Pulsed field gel electrophoresis of clindamycin-resistant clinical isolates. Lane 1: lamda ladder. Lane 2: representative USA300 
isolate. Lanes 3–10: isolates collected from two hospitals in the western part of the city. Lane 11: representative USA400 iso-
late. Lanes 12–15: isolates from a hospital in the eastern part of the city. Lanes 16–27: isolates collected from three hospitals in 
the western part of the city.
Table 2: Comparison of neighborhoods with low and high prevalence rates for S. aureus isolates belonging to the USA300 clone.
Region characteristic Western (low prevalence) neighborhoods Eastern (high prevalence) neighborhoods
White 61.4% 19.0% P < 0.001
Black 14.7% 60.1% P < 0.001
Asian 12.1% 2.5% P < 0.001
Hispanic 17.1% 24.1% P < 0.001
Female 50.8% 54.4% P < 0.001
Age < 18 years 22.8% 30.6% P < 0.001
Residents Medicaid eligible 31.5% 41.3% P < 0.001
Residents on Public Assistance 3.5% 8.5% P < 0.001
Households with ≥ 3 persons 41.1% 51.3% P < 0.001
New HIV diagnoses 9.1 cases per 100,000 61.7 cases per 100,000 P < 0.001
Average household income (Mean ± SD) $45,435 ± 16,132 $30,477 ± 9,461 P < 0.001Annals of Clinical Microbiology and Antimicrobials 2006, 5:29 http://www.ann-clinmicrob.com/content/5/1/29
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likely to be black and female when compared to patients
with infections due to MSSA [2]. The USA300 type pre-
dominated in this study, and the medical center served a
largely black and indigent population [2]. In Minnesota,
patients with cultures with CA-MRSA were more likely to
be younger, nonwhite, and of lower socioeconomic status
when compared to patients with hospital-acquired strains
of MRSA [4]. In a multicenter study involving patients
from Atlanta, Baltimore, and Minnesota, patients with
CA-MRSA were likely to have several underlying condi-
tions (e.g., tobacco use, prior skin infections, diabetes
mellitus, asthma, and HIV infection) and were of lower
socioeconomic status; isolates in this report were not fin-
gerprinted [14]. In a nationwide survey examining rates of
nasal colonization, S. aureus was more common in men,
those with asthma, and in subjects < 65 years of age;
blacks and Mexicans had lower colonization rates when
compared to whites. Risk factors for MRSA colonization
included age > 65 years, female sex, underlying diabetes
mellitus, and residence in a long-term care facility; His-
panics were less likely than whites to be colonized with
MRSA [3]. However, approximately half of the MRSA iso-
lates in the last study possessed SCCmec II, suggesting that
many were hospital-associated strains.
As the boundary between cases with nosocomial and
community-associated MRSA becomes hazy, it is increas-
ingly apparent that future epidemiological studies will
require thorough characterization of the bacterial isolates.
In this report, only 35% of our isolates with the antibiotic
phenotype suggestive of CA-MRSA (MRSA susceptible to
clindamycin) belonged to the USA300/400 types. In addi-
tion, only 62% of isolates with SCCmec type IV belonged
to the USA300/400 types; whether the other isolates rep-
resent CA-MRSA strains unique to our region requires fur-
ther investigation.
In this report, we performed a population-based analysis
of CA-MRSA in Brooklyn, NY using all S. aureus isolates
identified in hospital microbiology laboratories. By itself,
Brooklyn would rank as the fourth largest city in the
United States, and has an extremely heterogeneous popu-
lation. In this urban setting, we found a higher prevalence
of USA300 strains in neighborhoods with several distin-
guishing characteristics. Neighborhoods with a higher
prevalence of USA300 had a greater proportion of blacks,
Hispanics, females, and children, and had measures indic-
ative of a disadvantaged socioeconomic status. As more
households had ≥ 3 persons in the high prevalence neigh-
borhoods, crowded living conditions are likely an impor-
tant contributing factor for the spread of the USA300
strain. Although racial and ethnic risk factors have been
noted in other studies of CA-MRSA [2-4], it remains to be
determined if these features are causal in nature or just
reflect lower socioeconomic status (and crowded living
conditions).
Our results are in stark contrast to a prior study examining
epidemiology of Streptococcus pneumoniae in Brooklyn
[18]. In that report, the western region of the city (identi-
fied with the lower prevalence of USA300) had a higher
rate of penicillin-resistant S. pneumoniae, and was attrib-
uted to greater access to healthcare (and antimicrobial
agents). Indeed, increased antibiotic consumption has
been postulated as a protective factor against CA-MRSA in
certain populations [3]. It is evident that in a large urban
setting, these two resistant community pathogens do not
share similar epidemiological characteristics.
Conclusion
The USA300 strain of CA-MRSA is emerging in Brooklyn,
NY. In this population-based study, urban regions with
characteristics of lower socioeconomic status and with
evidence of overcrowding appear to have a higher preva-
lence of this pathogen.
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